// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A review of the outcomes of women with rheumatoid arthritis (RA treated with biologic agents attending the sheffield combined obstetrics and rheumatology clinic 2002 to 2013

R. Smith - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

A study to investigate whether if any barriers in ethnic minority patients may impact on research participation in a district general hospital (2011

V Ramasamy - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A summary of clinical evidence for commonly used uricosurics for gout in europe

F. Perez-Ruiz - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

Sulfinpyrazone

A systematic literature review of omega 3 in the treatment of rheumatoid arthritis

M. Prince - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

a systematic review and critical appraisal of economic evaluations in systemic lupus erythematosus

S. P. Gavan - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

A systematic review of online interventions for addressing psychological distress in rheumatoid arthritis and other long-term conditions

K. Fishpool - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

A uk study: vocational experiences of young adults with juvenile idiopathic arthritis

L.E. Lunt - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

A validation of the 2017 eular/acr idiopathic inflammatory myopathies classification criteria in an expert-defined single-centre ten year incident cohort

M.J.S Parker - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic inflammatory myopathies

N/A

A validation study of the global antiphospholipid syndrome score (GAPSS in women with systemic lupus erythematosus and pregnancy morbidity

K. Schreiber - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

A validation study of the pregnancy morbidity questionnaire(PMQ in women with antiphospholipid antibodies and pregnancy morbidity

K. Schreiber - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

A week to tweet: findings from young pare’s online course for twitter novices

S.R. Stones - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ability of the reductive x-ray score for psoriatic arthritis (REXSPA to detect change in an observational cohort of patients with psa

A. Antony - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Activated stromal cells induce ccl20 release and t cell migration

G. Cafaro - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Activation of mertk+cd206+ subpopulation of human synovial tissue-resident macrophages limits inflammatory response

S.R. Finlay - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acute paraspinal muscle necrosis with crack cocaine and heroin; a case report

A. Masood - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rhabdomyolysis

N/A

Adaptation and validation of the ankylosing spondylitis quality of life (ASQOL questionnaire for use in serbia

M. I. Zlatkovic-Svenda - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Adaptation and validation of the rheumatoid arthritis quality of life (RAQOL scale for portugal

F. Fernandes - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Addressing key challenges of lay involvement in musculoskeletal research: co-applicants and trial steering committees

A. Higginbottom - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adherence to rcophth guidelines in monitoring of hydroxychloroquine by rheumatologists at lnwh cmh

Q Adamjee - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Advanced metrology in patiens with axial spondyloarthritis: lumbar or thoracic+lumbar measurements for spinal mobility assessment?

I.C. Aranda-Valera - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved